158 related articles for article (PubMed ID: 38338900)
1. A Comparative Pharmacokinetic Study for Cysteamine-Containing Eye Drops as an Orphan Topical Therapy in Cystinosis.
Csorba A; Katona G; Budai-Szűcs M; Balogh-Weiser D; Molnár P; Maka E; Kazsoki A; Vajna M; Zelkó R; Nagy ZZ; Balogh GT
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338900
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of topical cysteamine therapy in the CTNS(-/-) knockout mouse using in vivo confocal microscopy.
Simpson JL; Nien CJ; Flynn KJ; Jester JV
Mol Vis; 2011; 17():2649-54. PubMed ID: 22065917
[TBL] [Abstract][Full Text] [Related]
3. [Ocular treatment of cystinosis with eye drop containing cysteamine].
Csorba A; Maka E; Szabó A; Kelen K; Reusz G; Nagy ZZ
Orv Hetil; 2022 May; 163(21):846-852. PubMed ID: 35598215
[TBL] [Abstract][Full Text] [Related]
4. Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops.
Gahl WA; Kuehl EM; Iwata F; Lindblad A; Kaiser-Kupfer MI
Mol Genet Metab; 2000; 71(1-2):100-20. PubMed ID: 11001803
[TBL] [Abstract][Full Text] [Related]
5. Synergistic Cysteamine Delivery Nanowafer as an Efficacious Treatment Modality for Corneal Cystinosis.
Marcano DC; Shin CS; Lee B; Isenhart LC; Liu X; Li F; Jester JV; Pflugfelder SC; Simpson J; Acharya G
Mol Pharm; 2016 Oct; 13(10):3468-3477. PubMed ID: 27571217
[TBL] [Abstract][Full Text] [Related]
6. A new gel formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis: the Cystadrops OCT-1 study.
Labbé A; Baudouin C; Deschênes G; Loirat C; Charbit M; Guest G; Niaudet P
Mol Genet Metab; 2014 Mar; 111(3):314-320. PubMed ID: 24440466
[TBL] [Abstract][Full Text] [Related]
7. [Cysteamine eyedrops for treatment of corneal cysteine deposits in infantile cystinosis].
Gräf M; Grote A; Wagner F
Klin Monbl Augenheilkd; 1992 Jul; 201(1):48-50. PubMed ID: 1513127
[TBL] [Abstract][Full Text] [Related]
8. A sustained release cysteamine microsphere/thermoresponsive gel eyedrop for corneal cystinosis improves drug stability.
Jimenez J; Washington MA; Resnick JL; Nischal KK; Fedorchak MV
Drug Deliv Transl Res; 2021 Oct; 11(5):2224-2238. PubMed ID: 33543397
[TBL] [Abstract][Full Text] [Related]
9. A New Viscous Cysteamine Eye Drops Treatment for Ophthalmic Cystinosis: An Open-Label Randomized Comparative Phase III Pivotal Study.
Liang H; Labbé A; Le Mouhaër J; Plisson C; Baudouin C
Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2275-2283. PubMed ID: 28426870
[TBL] [Abstract][Full Text] [Related]
10. A randomized clinical trial of topical cysteamine disulfide (cystamine) versus free thiol (cysteamine) in the treatment of corneal cystine crystals in cystinosis.
Iwata F; Kuehl EM; Reed GF; McCain LM; Gahl WA; Kaiser-Kupfer MI
Mol Genet Metab; 1998 Aug; 64(4):237-42. PubMed ID: 9758713
[TBL] [Abstract][Full Text] [Related]
11. NIH conference. Cystinosis: progress in a prototypic disease.
Gahl WA; Thoene JG; Schneider JA; O'Regan S; Kaiser-Kupfer MI; Kuwabara T
Ann Intern Med; 1988 Oct; 109(7):557-69. PubMed ID: 3048161
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of topical cysteamine in nephropathic cystinosis.
Al-Hemidan A; Shoughy SS; Kozak I; Tabbara KF
Br J Ophthalmol; 2017 Sep; 101(9):1234-1237. PubMed ID: 28057644
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of NACA and diNACA in human cystinosis fibroblast cell cultures as potential treatments for cystinosis.
Hector E; Cairns D; Michael Wall G
Orphanet J Rare Dis; 2022 Jun; 17(1):231. PubMed ID: 35710564
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of treatment with cysteamine eyedrops for cystinosis with confocal microscopy.
Tavares R; Coelho D; Macário MC; Torres A; Quadrado MJ; Murta J
Cornea; 2009 Sep; 28(8):938-40. PubMed ID: 19654516
[TBL] [Abstract][Full Text] [Related]
15. Effects of long-term cysteamine treatment in patients with cystinosis.
Ariceta G; Giordano V; Santos F
Pediatr Nephrol; 2019 Apr; 34(4):571-578. PubMed ID: 29260317
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of CTNS mutations in Tunisian patients with ocular cystinosis.
Chkioua L; Amri Y; Saheli C; Mili W; Mabrouk S; Chabchoub I; Boudabous H; Azzouz WB; Turkia HB; Ferchichi S; Tebib N; Massoud T; Ghorbel M; Laradi S
Diagn Pathol; 2022 May; 17(1):44. PubMed ID: 35524314
[TBL] [Abstract][Full Text] [Related]
17. Spectral domain optical coherence tomography-based retinochoroidal cystine crystal score: a window into infantile nephropathic cystinosis.
Keidel L; Hohenfellner K; Schworm B; Priglinger S; Luft N; Priglinger C
Br J Ophthalmol; 2023 Feb; 107(2):234-241. PubMed ID: 34531199
[TBL] [Abstract][Full Text] [Related]
18. [Cysteamine ophthalmic hydrogel for the treatment of ocular cystinosis].
Fernández-Ferreiro A; Luaces-Rodríguez A; Díaz-Tomé V; Gil-Martínez M; Rodríguez Ares MT; Touriño Peralba R; Blanco-Méndez J; González-Barcia M; Otero-Espinar FJ; Lamas MJ
Farm Hosp; 2017 Nov; 41(6):678-687. PubMed ID: 29112493
[TBL] [Abstract][Full Text] [Related]
19. Ophthalmic Outcome in a Belgian Cohort of Cystinosis Patients Treated with a Compounded Preparation of Cysteamine Eye Drops: Retrospective Analysis.
Peeters F; Cassiman C; Van Keer K; Levtchenko E; Veys K; Casteels I
Ophthalmol Ther; 2019 Dec; 8(4):623-633. PubMed ID: 31560113
[TBL] [Abstract][Full Text] [Related]
20. Analysis of tear film in cystinosis patients treated with topical viscous cysteamine hydrochloride (Cystadrops
Sergio P; Giancarlo I; Matteo F; Maria SC; Gianni P; Parrilla R; Valente P; Luca B
Eur J Ophthalmol; 2022 Nov; 32(6):3358-3362. PubMed ID: 35125035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
